DK2068899T3 - Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner - Google Patents

Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner Download PDF

Info

Publication number
DK2068899T3
DK2068899T3 DK07838266.0T DK07838266T DK2068899T3 DK 2068899 T3 DK2068899 T3 DK 2068899T3 DK 07838266 T DK07838266 T DK 07838266T DK 2068899 T3 DK2068899 T3 DK 2068899T3
Authority
DK
Denmark
Prior art keywords
existence
duration
reduce
lactobacillus acidophilus
infections
Prior art date
Application number
DK07838266.0T
Other languages
English (en)
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2068899(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK2068899T3 publication Critical patent/DK2068899T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK07838266.0T 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner DK2068899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02
PCT/US2007/020033 WO2008042101A2 (en) 2006-10-02 2007-09-14 Probiotics for use in reducing the incidence and duration of illness

Publications (1)

Publication Number Publication Date
DK2068899T3 true DK2068899T3 (da) 2015-09-28

Family

ID=39268947

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14186663.2T DK2839836T4 (da) 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom
DK07838266.0T DK2068899T3 (da) 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14186663.2T DK2839836T4 (da) 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom

Country Status (13)

Country Link
US (5) US20100040579A1 (da)
EP (2) EP2068899B1 (da)
JP (3) JP5896589B2 (da)
KR (2) KR101485200B1 (da)
CN (1) CN101528244B (da)
AU (1) AU2007302715B2 (da)
BR (1) BRPI0719787A2 (da)
DK (2) DK2839836T4 (da)
ES (2) ES2650375T3 (da)
FI (1) FI2839836T4 (da)
MX (1) MX2009003260A (da)
PL (2) PL2839836T3 (da)
WO (1) WO2008042101A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011068371A2 (ko) 2009-12-02 2011-06-09 주식회사 케이엠더블유 디바이스 선택 구조
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
PT3111942T (pt) 2013-11-15 2021-03-23 Nestle Sa Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
RU2720201C2 (ru) 2015-03-05 2020-04-27 Сосьете Де Продюи Нестле С.А. Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста
US11638726B2 (en) 2019-09-25 2023-05-02 Tall Goods Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
CA2271930C (en) * 1996-11-29 2006-10-17 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
OA13142A (en) * 2002-10-11 2006-12-13 Wyeth Corp Nutritional formulations containing synbiotic substances.
CA2550106A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
JP4777365B2 (ja) * 2005-02-15 2011-09-21 シャーウッド エル． ゴルバック プロバイオティクスおよび単離されたβ−グルカンを含有する食物ならびにその使用方法
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
DK1951273T3 (da) 2005-10-06 2014-05-05 Probi Ab Anvendelse af lactobacillus til behandling af autoimmune sygdomme

Also Published As

Publication number Publication date
EP2068899A2 (en) 2009-06-17
CN101528244B (zh) 2012-01-11
US20140356329A1 (en) 2014-12-04
MX2009003260A (es) 2009-05-11
US20100040579A1 (en) 2010-02-18
JP2014058558A (ja) 2014-04-03
CN101528244A (zh) 2009-09-09
US20230256037A1 (en) 2023-08-17
KR20140002069A (ko) 2014-01-07
ES2650375T3 (es) 2018-01-18
US20200316145A1 (en) 2020-10-08
DK2839836T4 (da) 2024-08-26
EP2839836B1 (en) 2017-08-30
KR20090063222A (ko) 2009-06-17
JP2010505824A (ja) 2010-02-25
PL2839836T3 (pl) 2018-02-28
AU2007302715B2 (en) 2013-01-31
BRPI0719787A2 (pt) 2014-11-25
KR101474188B1 (ko) 2014-12-17
US20180000875A1 (en) 2018-01-04
WO2008042101A2 (en) 2008-04-10
EP2839836B2 (en) 2024-06-26
WO2008042101A3 (en) 2009-04-09
JP2016128478A (ja) 2016-07-14
ES2547480T3 (es) 2015-10-06
FI2839836T4 (fi) 2024-08-26
PL2068899T3 (pl) 2015-12-31
KR101485200B1 (ko) 2015-01-26
AU2007302715A1 (en) 2008-04-10
JP5896589B2 (ja) 2016-03-30
EP2839836A1 (en) 2015-02-25
DK2839836T3 (da) 2017-12-04
EP2068899B1 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
DK2068899T3 (da) Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner
HK1210142A1 (en) Hcv protease inhibitors and uses thereof hcv
HK1210141A1 (en) Hcv protease inhibitors and uses thereof hcv
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2209806T3 (da) Anti-hepcidin-antistoffer og anvendelser deraf
PL2099826T3 (pl) Przeciwciało przeciwko beta-amyloidowi i jego zastosowania
DK1853284T3 (da) Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum
EP2021555A4 (en) STRUCTURAL ELEMENT AND METHODS OF USE THEREOF
BRPI0819573A2 (pt) Composição e artigo
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2222706T3 (da) Antibodies against human nkg2d and uses thereof
EP2236604A4 (en) ANTI-NR10 ANTIBODIES AND USE THEREOF
DK3586901T3 (da) Kateteriseringsindretning og kit
PL2132987T3 (pl) Kompozycja środka nicieniobójczego oraz sposób jej zastosowania
DK2087094T3 (da) Lactobacillus fermentum ess-1, dsm17851 og dets anvendelse til behandlingen og/eller forebyggelse af candidiasis og urinvejsinfektioner
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
CR20130360A (es) Compuesto heterocíclico y su uso
DK2172515T3 (da) Gummiforbindelse og støbt artikel
IL200576A0 (en) Inhibitors of rtp801 and their uses
DK2328931T3 (da) Selektive anti-hepcidin-25-antistoffer og anvendelser deraf
HK1203206A1 (en) Antibody and use thereof
DK2176284T3 (da) Lantibiotika og anvendelser deraf
DE602007006888D1 (de) Leistungsumwandlungssystem und -verfahren
CR10430A (es) Aminothiazoles and their uses